-
- Posted Friday April 10, 2015
AZ Business magazine picks TGen's Dr. Daniel Von Hoff as its 2015 Researcher of the Year
Dr. Von Hoff directs clinical trials, translating research discoveries into new treatments for patients
PHOENIX, Ariz. - April 10, 2015 - AZ
Business magazine has named Dr. Daniel D. Von Hoff of the Translational
Genomics Research Institute (TGen) as its 2015 Researcher of
the Year.
The magazine - part of AZ Big Media, which is celebrating "30
Years of Excellence" - announced Dr. Von Hoff's recognition at its
Healthcare Leadership Awards dinner April 9 in Phoenix.
Dr. Von Hoff, M.D., TGen's Distinguished Professor and
Physician-In-Chief, directs clinical trials at the Virginia G.
Piper Cancer Center Clinical Trials at HonorHealth that translates
TGen research discoveries into new treatments for patients.
"I am honored to be named AZ Business magazine's
Researcher of the Year, especially in light of the other fine
physician-scientists nominated," said Dr. Von Hoff. "Our work in
translation of laboratory discoveries into clinical trials is
vitally important for the many patients who we all strive to
help."
Others nominated for the magazine's Researcher of the Year were:
Dr. Glen Weiss, M.D., of Cancer Treatment Centers of America (CTCA)
at Western Regional Medical Center (Western) in Goodyear, Ariz.;
Dr. David Jacofsky, M.D., Chairman of The CORE Institute.
Keynote speaker at the event was Dr. Connie Mariano, former White
House Physician to the President and first woman Director of the
White House Medical Unit, whose new book is titled The White
House Doctor: My Patients were Presidents.
Also honored at the event for a Lifetime Achievement Award was
Peter Fine, President and CEO of Banner Health, and a former
executive with health systems in Wisconsin, Illinois and
Indiana.
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]